148 related articles for article (PubMed ID: 16547350)
1. Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo.
Del Borgo MP; Hughes RA; Bathgate RAD; Lin F; Kawamura K; Wade JD
J Biol Chem; 2006 May; 281(19):13068-13074. PubMed ID: 16547350
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
3. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor.
Shabanpoor F; Zhang S; Hughes RA; Hossain MA; Layfield S; Ferraro T; Bathgate RA; Separovic F; Wade JD
Biopolymers; 2011; 96(1):81-7. PubMed ID: 20560146
[TBL] [Abstract][Full Text] [Related]
4. Solution structure and characterization of the LGR8 receptor binding surface of insulin-like peptide 3.
Rosengren KJ; Zhang S; Lin F; Daly NL; Scott DJ; Hughes RA; Bathgate RA; Craik DJ; Wade JD
J Biol Chem; 2006 Sep; 281(38):28287-95. PubMed ID: 16867980
[TBL] [Abstract][Full Text] [Related]
5. Defining the LGR8 residues involved in binding insulin-like peptide 3.
Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA
Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281
[TBL] [Abstract][Full Text] [Related]
6. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2.
Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD
Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702
[TBL] [Abstract][Full Text] [Related]
7. Leucine-rich repeat-containing G-protein-coupled receptor 8 in mature glomeruli of developing and adult rat kidney and inhibition by insulin-like peptide-3 of glomerular cell proliferation.
Fu P; Shen PJ; Zhao CX; Scott DJ; Samuel CS; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
J Endocrinol; 2006 May; 189(2):397-408. PubMed ID: 16648305
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, conformation, receptor binding and biological activities of monobiotinylated human insulin-like peptide 3.
Fu P; Layfield S; Ferraro T; Tomiyama H; Hutson J; Otvos L; Tregear GW; Bathgate RA; Wade JD
J Pept Res; 2004 Feb; 63(2):91-8. PubMed ID: 15009530
[TBL] [Abstract][Full Text] [Related]
9. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent.
Kumagai J; Hsu SY; Matsumi H; Roh JS; Fu P; Wade JD; Bathgate RA; Hsueh AJ
J Biol Chem; 2002 Aug; 277(35):31283-6. PubMed ID: 12114498
[TBL] [Abstract][Full Text] [Related]
10. Genetic targeting of relaxin and insl3 signaling in mice.
Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
[TBL] [Abstract][Full Text] [Related]
11. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis.
Anand-Ivell RJ; Relan V; Balvers M; Coiffec-Dorval I; Fritsch M; Bathgate RA; Ivell R
Biol Reprod; 2006 May; 74(5):945-53. PubMed ID: 16467492
[TBL] [Abstract][Full Text] [Related]
12. The active form of goat insulin-like peptide 3 (INSL3) is a single-chain structure comprising three domains B-C-A, constitutively expressed and secreted by testicular Leydig cells.
Siqin ; Minagawa I; Okuno M; Yamada K; Sugawara Y; Nagura Y; Hamano K; Park EY; Sasada H; Kohsaka T
Biol Chem; 2013 Sep; 394(9):1181-94. PubMed ID: 23934571
[TBL] [Abstract][Full Text] [Related]
13. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization.
Ferlin A; Bogatcheva NV; Gianesello L; Pepe A; Vinanzi C; Agoulnik AI; Foresta C
Mol Hum Reprod; 2006 Jun; 12(6):401-6. PubMed ID: 16687567
[TBL] [Abstract][Full Text] [Related]
15. Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3.
Luo X; Bathgate RA; Liu YL; Shao XX; Wade JD; Guo ZY
FEBS J; 2009 Sep; 276(18):5203-11. PubMed ID: 19674100
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the rat INSL3 receptor.
Scott DJ; Fu P; Shen PJ; Gundlach A; Layfield S; Riesewijk A; Tomiyama H; Hutson JM; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():13-6. PubMed ID: 15956681
[TBL] [Abstract][Full Text] [Related]
17. Partial cDNA sequence of a relaxin-like factor (RLF) receptor, LGR8 and possible existence of the RLF ligand-receptor system in goat testes.
Siqin ; Nakai M; Hagi T; Kato S; Pitia AM; Kotani M; Odanaka Y; Sugawara Y; Hamano K; Yogo K; Nagura Y; Fujita M; Sasada H; Sato E; Kohsaka T
Anim Sci J; 2010 Dec; 81(6):681-6. PubMed ID: 21108688
[TBL] [Abstract][Full Text] [Related]
18. The insulin-like factor 3 (INSL3)-receptor (RXFP2) network functions as a germ cell survival/anti-apoptotic factor in boar testes.
Sagata D; Minagawa I; Kohriki H; Pitia AM; Uera N; Katakura Y; Sukigara H; Terada K; Shibata M; Park EY; Hasegawa Y; Sasada H; Kohsaka T
Endocrinology; 2015 Apr; 156(4):1523-39. PubMed ID: 25562614
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to diaethylstilbestrol in the rat inhibits transabdominal testicular descent with involvement of the INSL3/LGR8 system and HOXA10.
Zhang L; Zheng XM; Hubert J; Zheng H; Yang ZW; Li SW
Chin Med J (Engl); 2009 Apr; 122(8):967-71. PubMed ID: 19493424
[TBL] [Abstract][Full Text] [Related]
20. GREAT/LGR8 is the only receptor for insulin-like 3 peptide.
Bogatcheva NV; Truong A; Feng S; Engel W; Adham IM; Agoulnik AI
Mol Endocrinol; 2003 Dec; 17(12):2639-46. PubMed ID: 12933905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
